Apeloa Pharmaceutical repurchases 1.08% of shares for employee incentives

Apeloa Pharmaceutical announced that as of December 22, 2025, it has repurchased 12,550,000 shares, representing 1.08% of its current total share capital. The buyback was executed through centralized bidding on a dedicated securities account.

The shares were acquired at a maximum price of RMB16.85 per share and a minimum price of RMB15.91 per share, totaling an aggregate transaction amount of RMB203,798,128.40 (excluding transaction fees).

The company's board of directors approved the buyback plan on November 18, 2025, with the intention to use the repurchased shares for equity incentives or an employee stock ownership plan. The initial plan authorized a buyback of no less than RMB180,000,000 and no more than RMB360,000,000, at a price not exceeding RMB23 per share, over a 12-month period.

Apeloa Pharmaceutical confirmed that this buyback aligns with its approved plan and relevant legal requirements. The company intends to continue implementing the share buyback program within the specified period.